Amorphous nickel based alloy catalysts (denoted as the SRNAseries catalysts) were prepared viarapid quenching method followed by alkali leaching and other activation procedures. The physicochemicalcharacterizations sh...Amorphous nickel based alloy catalysts (denoted as the SRNAseries catalysts) were prepared viarapid quenching method followed by alkali leaching and other activation procedures. The physicochemicalcharacterizations show that nickel, the active component in these catalysts, exists in the amorphous state, andthe catalyst particles possess many nanosized voids leading to large surface area (the highest is 145m2/g). Theevaluation results in some model reactions show that the SRNA series catalysts have 2 to 4 times higheractivity and selectivity than conventional Raney Ni catalyst for the hydrogenation of compounds with unsatur-ated functional groups. At present, the SRNA series catalysts have been successfully used in hydrogenation ofglucose, hydrogenation of pharmaceutical intermediates and purification of caprolactam. In order to use thesecatalysts efficiently, a magnetically stabilized bed (MSB) technology has been developed by combining theferromagnetic property of the catalyst with the good mass transfer characteristics of MSB. The demonstrationunit of MSB hydrogenation technology has been set up and has kept running for 2800 hours. The results showthat, after running 2800 hours, the catalyst still retained good activity; meanwhile, the hydrogenation effi-ciency had been improved 10 times in comparison with the traditional CSTR process.展开更多
文摘Amorphous nickel based alloy catalysts (denoted as the SRNAseries catalysts) were prepared viarapid quenching method followed by alkali leaching and other activation procedures. The physicochemicalcharacterizations show that nickel, the active component in these catalysts, exists in the amorphous state, andthe catalyst particles possess many nanosized voids leading to large surface area (the highest is 145m2/g). Theevaluation results in some model reactions show that the SRNA series catalysts have 2 to 4 times higheractivity and selectivity than conventional Raney Ni catalyst for the hydrogenation of compounds with unsatur-ated functional groups. At present, the SRNA series catalysts have been successfully used in hydrogenation ofglucose, hydrogenation of pharmaceutical intermediates and purification of caprolactam. In order to use thesecatalysts efficiently, a magnetically stabilized bed (MSB) technology has been developed by combining theferromagnetic property of the catalyst with the good mass transfer characteristics of MSB. The demonstrationunit of MSB hydrogenation technology has been set up and has kept running for 2800 hours. The results showthat, after running 2800 hours, the catalyst still retained good activity; meanwhile, the hydrogenation effi-ciency had been improved 10 times in comparison with the traditional CSTR process.
